{"schema_version":"secwatch.filing_event.v1","accession":"0001683168-26-005555","form_type":"8-K","ticker":"ISCO","cik":"0001355790","company_name":"International Stem Cell CORP","filed_at":"2026-07-16T00:11:52+00:00","discovered_at":"2026-07-16T10:05:00.274140+00:00","generated_at":"2026-07-16T10:05:10.885407+00:00","sec_items":["1.01","9.01"],"event_type":"m_and_a","sentiment":"neutral","materiality_score":0.75,"calibrated_materiality_score":0.75,"confidence":"high","headline":"ISCO agrees to sell Lifeline Cell Technology to ATCC for $25M in cash","bullets":["Purchase price $25M, subject to net working capital, cash, and debt adjustments; closing expected Q3 2026.","Seller must obtain stockholder consent from requisite holders; support agreements already signed for >50% voting power.","Indemnity escrow of $2.5M and adjustment escrow of $100K; post-closing adjustment process with 90-day review.","Transition services agreement to be effective at closing; non-solicitation and non-compete covenants for 5 years post-closing.","LCT develops and sells primary human cells, stem cells, and cell culture media for scientific research."],"urls":{"canonical":"https://secwatch.observer/filing/0001683168-26-005555","json":"https://secwatch.observer/filing/0001683168-26-005555.json","markdown":"https://secwatch.observer/filing/0001683168-26-005555.md","text":"https://secwatch.observer/filing/0001683168-26-005555.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1355790/000168316826005555/0001683168-26-005555-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1355790/000168316826005555/intlstemcell_8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-07-16T10:05:10.885407+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}